This dual action in the gut and brain translates into reduced food intake and supports sustained weight loss
The US Food and Drug Administration has reported shortages of the GLP-1 medications Ozempic, Wegovy and Mounjaro at various dosages over the past year as drugmakers have raced to keep up with skyrocketing demand
FDA was denied by a district court in early March
The Concern: A Rare Vision Condition (NA-AION) Some early reports suggested a link between GLP-1 drugs and non-arteritic anterior ischemic optic neuropathy (NA-AION)
Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
